Nanotechnology sheds light on cancer stem cell therapy

A new nanotechnology breakthrough is helping scientists and oncologists evaluate why a certain subset of early-stage cancer cells, called cancer stem cells (CSC), are resistant to many front-line chemotherapy drugs. It's also offering a faster and cheaper methodology for the development of more effective therapeutics. Led by Jackie Y. Ying, a professor and executive director at the Institute of Bioengineering and Nanotechnology (IBN), a team of researchers developed a...